Skip to main content

Table 1 Baseline patient and treatment characteristics

From: Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer

  

Patients (N = 101)

Age (y/o)

Median 72 (47–88)

 
 

Age ≤ 60

13.9 %

 

60 < Age ≤ 70

51.5 %

 

Age > 70

34.6 %

Race

White

55.6 %

 

Black

26.8 %

 

Other

17.6 %

Median prostate volume (cc)

Median: 43 (14.0–170.7) cc

 

Risk groups (D’Amico’s)

Low

36.3 %

 

Intermediate

54.9 %

 

High

7.8 %

ADT

 

8.9 %

Baseline AUA score

Median: 9.5

 
 

Mild (1–7):

41.6 %

 

Moderate (8–19):

41.6 %

 

Severe (20–35):

16.8 %

Baseline SHIM score

Median: 15

 
 

Severe ED (1–7):

34.2 %

 

Moderate ED (8–11):

10.5 %

 

Mild-Moderate ED (12–16):

7.9 %

 

Mild ED (17–21):

21.1 %

 

Normal function (>21):

26.3 %